Top Big Cap Negative News Movers Premarket: XENE: -23% Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.